Assessment of prognostic factors in pediatric adrenocortical tumors: a systematic review and evaluation of a modified S-GRAS score

in European Journal of Endocrinology
Authors:
Maria Riedmeier Division of Pediatric Hematology, Oncology and Stem Cell Transplantation, Department of Pediatrics, University Hospital, University of Wuerzburg, Wuerzburg, Germany

Search for other papers by Maria Riedmeier in
Current site
Google Scholar
PubMed
Close
,
Boris Decarolis Department of Pediatric Oncology and Hematology, University Children’s Hospital of Cologne, Medical Faculty, Cologne, Germany

Search for other papers by Boris Decarolis in
Current site
Google Scholar
PubMed
Close
,
Imme Haubitz Division of Pediatric Hematology, Oncology and Stem Cell Transplantation, Department of Pediatrics, University Hospital, University of Wuerzburg, Wuerzburg, Germany

Search for other papers by Imme Haubitz in
Current site
Google Scholar
PubMed
Close
,
Joachim Reibetanz Department of General, Visceral, Transplantation, Vascular and Pediatric Surgery, University Hospital, University of Wuerzburg, Wuerzburg, Germany

Search for other papers by Joachim Reibetanz in
Current site
Google Scholar
PubMed
Close
,
Armin Wiegering Department of General, Visceral, Transplantation, Vascular and Pediatric Surgery, University Hospital, University of Wuerzburg, Wuerzburg, Germany
Department of Biochemistry and Molecular Biology, University of Wuerzburg, Wuerzburg, Germany
Comprehensive Cancer Centre Mainfranken, University of Wuerzburg Medical Centre, Wuerzburg, Germany

Search for other papers by Armin Wiegering in
Current site
Google Scholar
PubMed
Close
https://orcid.org/0000-0001-7777-0909
,
Christoph Härtel Division of Pediatric Hematology, Oncology and Stem Cell Transplantation, Department of Pediatrics, University Hospital, University of Wuerzburg, Wuerzburg, Germany
Comprehensive Cancer Centre Mainfranken, University of Wuerzburg Medical Centre, Wuerzburg, Germany

Search for other papers by Christoph Härtel in
Current site
Google Scholar
PubMed
Close
,
Paul-Gerhardt Schlegel Division of Pediatric Hematology, Oncology and Stem Cell Transplantation, Department of Pediatrics, University Hospital, University of Wuerzburg, Wuerzburg, Germany
Comprehensive Cancer Centre Mainfranken, University of Wuerzburg Medical Centre, Wuerzburg, Germany

Search for other papers by Paul-Gerhardt Schlegel in
Current site
Google Scholar
PubMed
Close
,
Martin Fassnacht Comprehensive Cancer Centre Mainfranken, University of Wuerzburg Medical Centre, Wuerzburg, Germany
Division of Endocrinology and Diabetes, Department of Medicine, University Hospital, University of Wuerzburg, Wuerzburg, Germany

Search for other papers by Martin Fassnacht in
Current site
Google Scholar
PubMed
Close
https://orcid.org/0000-0001-6170-6398
, and
Verena Wiegering Division of Pediatric Hematology, Oncology and Stem Cell Transplantation, Department of Pediatrics, University Hospital, University of Wuerzburg, Wuerzburg, Germany
Comprehensive Cancer Centre Mainfranken, University of Wuerzburg Medical Centre, Wuerzburg, Germany

Search for other papers by Verena Wiegering in
Current site
Google Scholar
PubMed
Close
https://orcid.org/0000-0002-2802-4034

Correspondence should be addressed to V Wiegering; Email: Wiegering_v@ukw.de
Restricted access

USD  $0.01
USD  $0.01

USD  $0.01
USD  $0.01

USD  $0.01
USD  $0.01

Objective

Pediatric adrenocortical carcinoma (pACC) is rare and prognostic stratification remains challenging. We summarized the clinical prognostic factors of pACC and determined the prognostic value of the pediatric scoring system (pS-GRAS) in adaption to the recommendation (S-GRAS) of the European Network for the Study of Adrenal Tumors for the classification of adult ACC.

Design

Analysis of pACC patients of 33 available retrospective studies in the literature.

Methods

We searched the PubMed and Embase databases for manuscripts regarding pACC. The pS-GRAS score was calculated as a sum of tumor stage (1 = 0; 2–3 = 1; 4 = 2 points), grade (Ki67 index/rate of mitosis 0–9%/low = 0; 10–19%/intermediate = 1; ≥20%/high = 2 points), resection status (R0 = 0; RX = 1; R1 = 2; R2 = 3 points), age (<4 years = 0; ≥4 years = 1 point), hormone-related symptoms (androgen production = 0; glucocorticoid/mixed/no hormone production = 1 point) generating 10 scores and 4 groups (1: 0–2, 2: 3–4, 3: 5, 4: 6–9). The primary endpoint was overall survival (OS).

Results

We included 733 patients. The median age was 2.5 years and >85% of pACC showed hormone activity (mixed 50%, androgen 29%, glucocorticoid 21%). Androgen production was associated with a superior OS. Increasing age correlated with higher rates of inactive or only glucocorticoid-producing tumors, advanced tumor stage, and case fatality. Especially infants < 4 years showed more often low-risk constellations with an increased OS for all tumor stages. The pS-GRAS score correlated with clinical outcome; median OS was 133 months (95% CI: 36–283) in group 1 (n = 49), 110 months (95% CI: 2.9–314) in group 2 (n = 57), 49 months (95% CI: 5.8–278) in group 3 (n = 18), and 16 months (95% CI: 2.4–267) in group 4; (n = 11) P < 0.05).

Conclusion

The pS-GRAS score seems to have a high predictive value in the pACC patients, may serve as a helpful tool for risk stratification in future studies, and should be evaluated prospectively in an international context.

Supplementary Materials

 

  • Collapse
  • Expand

     European Society of Endocrinology

Sept 2018 onwards Past Year Past 30 Days
Abstract Views 6628 1577 1514
Full Text Views 117 0 0
PDF Downloads 145 0 0
  • 1

    Kerkhofs TM, Ettaieb MH, Verhoeven RH, Kaspers GJ, Tissing WJ, Loeffen J, Van den Heuvel-Eibrink MM, De Krijger RR, Haak HR. Adrenocortical carcinoma in children: first population-based clinicopathological study with long-term follow-up. Oncology Reports 2014 32 28362844. (https://doi.org/10.3892/or.2014.3506)

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 2

    Ribeiro RC, Sandrini F, Figueiredo B, Zambetti GP, Michalkiewicz E, Lafferty AR, DeLacerda L, Rabin M, Cadwell C & Sampaio G et al.An inherited p53 mutation that contributes in a tissue-specific manner to pediatric adrenal cortical carcinoma. PNAS 2001 98 93309335. (https://doi.org/10.1073/pnas.161479898)

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 3

    Pinto EM, Billerbeck AE, Villares MC, Domenice S, Mendonça BB, Latronico AC. Founder effect for the highly prevalent R337H mutation of tumor suppressor p53 in Brazilian patients with adrenocortical tumors. Arquivos Brasileiros de Endocrinologia e Metabologia 2004 48 647650. (https://doi.org/10.1590/s0004-27302004000500009)

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 4

    Bougeard G, Renaux-Petel M, Flaman JM, Charbonnier C, Fermey P, Belotti M, Gauthier-Villars M, Stoppa-Lyonnet D, Consolino E & Brugières L et al.Revisiting Li-Fraumeni syndrome from TP53 mutation carriers. Journal of Clinical Oncology 2015 33 23452352. (https://doi.org/10.1200/JCO.2014.59.5728)

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 5

    Peixoto Lira RC, Fedatto PF, Marco Antonio DS, Leal LF, Martinelli CE, de Castro M, Tucci S, Neder L, Ramalho L & Seidinger AL et al.IGF2 and IGF1R in pediatric adrenocortical tumors: roles in metastasis and steroidogenesis. Endocrine-Related Cancer 2016 23 481493. (https://doi.org/10.1530/ERC-15-0426)

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 6

    Almeida MQ, Fragoso MCBV, Lotfi CFP, Santos MG, Nishi MY, Costa MHS, Lerario AM, Maciel CC, Mattos GE & Jorge AAL et al.Expression of insulin-like growth factor-II and its receptor in pediatric and adult adrenocortical tumors. Journal of Clinical Endocrinology and Metabolism 2008 93 35243531. (https://doi.org/10.1210/jc.2008-0065)

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 7

    Wang Z, Liu G, Sun H, Li K, Dong K, Ma Y, Zheng S. Clinical characteristics and prognosis of adrenocortical tumors in children. Pediatric Surgery International 2019 35 365371. (https://doi.org/10.1007/s00383-018-4409-z)

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 8

    Zambaiti E, Duci M, De Corti F, Gamba P, Dall’Igna P, Ghidini F, Virgone C. Clinical prognostic factors in pediatric adrenocortical tumors: a meta-analysis. Pediatric Blood and Cancer 2021 68 e28836. (https://doi.org/10.1002/pbc.28836)

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 9

    Riedmeier M, Decarolis B, Haubitz I, Muller S, Uttinger K, Borner K, Reibetanz J, Wiegering A, Hartel C & Schlegel PG et al.Adrenocortical carcinoma in childhood: a systematic review. Cancers 2021 13 5266. (https://doi.org/10.3390/cancers13215266)

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 10

    Mendonca BB, Lucon AM, Menezes CA, Saldanha LB, Latronico AC, Zerbini C, Madureira G, Domenice S, Albergaria MA, Camargo MH. Clinical, hormonal and pathological findings in a comparative study of adrenocortical neoplasms in childhood and adulthood. Journal of Urology 1995 154 20042009. (https://doi.org/10.1016/S0022-5347(0166673-4)

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 11

    Lalli E, Figueiredo BC. Pediatric adrenocortical tumors: what they can tell us on adrenal development and comparison with adult adrenal tumors. Frontiers in Endocrinology 2015 6 23. (https://doi.org/10.3389/fendo.2015.00023)

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 12

    Dehner LP, Hill DA. Adrenal cortical neoplasms in children: why so many carcinomas and yet so many survivors? Pediatric and Developmental Pathology 2009 12 284291. (https://doi.org/10.2350/08-06-0489.1)

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 13

    Wieneke JA, Thompson LD, Heffess CS. Adrenal cortical neoplasms in the pediatric population: a clinicopathologic and immunophenotypic analysis of 83 patients. American Journal of Surgical Pathology 2003 27 867881. (https://doi.org/10.1097/00000478-200307000-00001)

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 14

    Michalkiewicz E, Sandrini R, Figueiredo B, Miranda EC, Caran E, Oliveira-Filho AG, Marques R, Pianovski MA, Lacerda L & Cristofani LM et al.Clinical and outcome characteristics of children with adrenocortical tumors: a report from the International Pediatric Adrenocortical Tumor Registry. Journal of Clinical Oncology 2004 22 838845. (https://doi.org/10.1200/JCO.2004.08.085)

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 15

    Fassnacht M, Wittekind C, Allolio B. Current TNM classification systems for adrenocortical carcinoma. Der Pathologe 2010 31 374378. (https://doi.org/10.1007/s00292-010-1306-1)

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 16

    Fassnacht M, Johanssen S, Quinkler M, Bucsky P, Willenberg HS, Beuschlein F, Terzolo M, Mueller HH, Hahner S & Allolio B et al.Limited prognostic value of the 2004 International Union against cancer staging classification for adrenocortical carcinoma: proposal for a revised TNM classification. Cancer 2009 115 243250. (https://doi.org/10.1002/cncr.24030)

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 17

    Elhassan YS, Altieri B, Berhane S, Cosentini D, Calabrese A, Haissaguerre M, Kastelan D, Fragoso MCBV, Bertherat J & Al Ghuzlan A et al.S-GRAS score for prognostic classification of adrenocortical carcinoma: an international, multicenter ENSAT study. European Journal of Endocrinology 2021 186 2536. (https://doi.org/10.1530/EJE-21-0510)

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 18

    Lippert J, Appenzeller S, Liang R, Sbiera S, Kircher S, Altieri B, Nanda I, Weigand I, Gehrig A & Steinhauer S et al.Targeted molecular analysis in adrenocortical carcinomas: a strategy toward improved personalized prognostication. Journal of Clinical Endocrinology and Metabolism 2018 103 45114523. (https://doi.org/10.1210/jc.2018-01348)

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 19

    Libé R, Borget I, Ronchi CL, Zaggia B, Kroiss M, Kerkhofs T, Bertherat J, Volante M, Quinkler M & Chabre O et al.Prognostic factors in stage III–IV adrenocortical carcinomas (ACC): an European Network for the study of adrenal tumor (ENSAT) study. Annals of Oncology 2015 26 21192125. (https://doi.org/10.1093/annonc/mdv329)

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 20

    Buccheri S, Sodeck GH, Capodanno D. Statistical primer: methodology and reporting of meta-analyses. European Journal of Cardio-Thoracic Surgery 2018 53 708713. (https://doi.org/10.1093/ejcts/ezy004)

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 21

    Sandrini R, Ribeiro RC, DeLacerda L. Childhood adrenocortical tumors. Journal of Clinical Endocrinology and Metabolism 1997 82 20272031. (https://doi.org/10.1210/jcem.82.7.4057)

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 22

    Letouze E, Rosati R, Komechen H, Doghman M, Marisa L, Fluck C, de Krijger RR, van Noesel MM, Mas JC & Pianovski MA et al.SNP array profiling of childhood adrenocortical tumors reveals distinct pathways of tumorigenesis and highlights candidate driver genes. Journal of Clinical Endocrinology and Metabolism 2012 97 E1284E1293. (https://doi.org/10.1210/jc.2012-1184)

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 23

    Jehangir S, Nanjundaiah P, Sigamani E, Burad D, Manipadam MT, Lea V, Ly T, Holland AJA. Pathological prognostication of paediatric adrenocortical tumours: is a gold standard emerging? Pediatric Blood and Cancer 2019 66 e27567. (https://doi.org/10.1002/pbc.27567)

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 24

    McDonnell CM, Zacharin MR. Adrenal cortical tumours: 25 years’ experience at the Royal Children’s Hospital, Melbourne. Journal of Paediatrics and Child Health 2003 39 682685. (https://doi.org/10.1046/j.1440-1754.2003.00268.x)

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 25

    Barbosa AS, Giacaglia LR, Martin RM, Mendonca BB, Lin CJ. Assessment of the role of transcript for GATA-4 as a marker of unfavorable outcome in human adrenocortical neoplasms. BMC Endocrine Disorders 2004 4 3. (https://doi.org/10.1186/1472-6823-4-3)

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 26

    Bergada I, Venara M, Maglio S, Ciaccio M, Diez B, Bergada C, Chemes H. Functional adrenal cortical tumors in pediatric patients: a clinicopathologic and immunohistochemical study of a long term follow-up series. Cancer 1996 77 771777. (https://doi.org/10.1002/(SICI)1097-0142(19960215)77:4<771::AID-CNCR24>3.0.CO;2-X)

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 27

    Chatterjee G, DasGupta S, Mukherjee G, Sengupta M, Roy P, Arun I, Datta C, Mishra PK, Banerjee S, Chatterjee U. Usefulness of Wieneke criteria in assessing morphologic characteristics of adrenocortical tumors in children. Pediatric Surgery International 2015 31 563571. (https://doi.org/10.1007/s00383-015-3708-x)

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 28

    Cho MJ, Kim DY, Kim SC, Kim TH, Kim IK. Adrenocortical tumors in children 18 years old and younger. Journal of the Korean Surgical Society 2012 82 246250. (https://doi.org/10.4174/jkss.2012.82.4.246)

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 29

    Damiani D, Della Manna T, Aquino LG, Dichtchekenian V, Avancini V, Alves F, Longatto Filho A, Kanamura CT, Setian N. Proliferating cell nuclear antigen immunoreaction in adrenal tumors. Tumori 1995 81 273277. (https://doi.org/10.1177/030089169508100412)

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 30

    Das S, Sengupta M, Islam N, Roy P, Datta C, Mishra PK, Banerjee S, Chaudhuri MK, Chatterjee U. Weineke criteria, Ki-67 index and p53 status to study pediatric adrenocortical tumors: is there a correlation? Journal of Pediatric Surgery 2016 51 17951800. (https://doi.org/10.1016/j.jpedsurg.2016.07.014)

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 31

    Doghman-Bouguerra M, Finetti P, Durand N, Parise IZS, Sbiera S, Cantini G, Canu L, Hescot S, Figueiredo MMO & Komechen H et al.Cancer-testis antigen FATE1 expression in adrenocortical tumors is associated with a pervasive autoimmune response and is a marker of malignancy in adult, but not children, ACC. Cancers 2020 12 689. (https://doi.org/10.3390/cancers12030689)

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 32

    Federici S, Galli G, Ceccarelli PL, Ferrari M, Cicognani A, Cacciari E, Domini R. Adrenocortical tumors in children: a report of 12 cases. European Journal of Pediatric Surgery 1994 4 2125. (https://doi.org/10.1055/s-2008-1066060)

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 33

    Gonc EN, Ozon ZA, Cakir MD, Alikasifoglu A, Kandemir N. Need for comprehensive hormonal workup in the management of adrenocortical tumors in children. Journal of Clinical Research in Pediatric Endocrinology 2014 6 6873. (https://doi.org/10.4274/Jcrpe.1351)

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 34

    Guntiboina VA, Sengupta M, Islam N, Barman S, Biswas SK, Chatterjee U, Mishra PK, Roy P, Mallick MG, Datta C. Diagnostic and prognostic utility of SF1, IGF2 and p57 immunoexpression in pediatric adrenal cortical tumors. Journal of Pediatric Surgery 2019 54 19061912. (https://doi.org/10.1016/j.jpedsurg.2018.12.002)

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 35

    Latronico AC, Pinto EM, Domenice S, Fragoso MC, Martin RM, Zerbini MC, Lucon AM, Mendonca BB. An inherited mutation outside the highly conserved DNA-binding domain of the p53 tumor suppressor protein in children and adults with sporadic adrenocortical tumors. Journal of Clinical Endocrinology and Metabolism 2001 86 49704973. (https://doi.org/10.1210/jcem.86.10.7957)

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 36

    Leal LF, Mermejo LM, Ramalho LZ, Martinelli CE Jr, Yunes JA, Seidinger AL, Mastellaro MJ, Cardinalli IA, Brandalise SR & Moreira AC et al.Wnt/beta-catenin pathway deregulation in childhood adrenocortical tumors. Journal of Clinical Endocrinology and Metabolism 2011 96 31063114. (https://doi.org/10.1210/jc.2011-0363)

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 37

    Loncarevic IF, Hering A, Posorski N, Linden T, Hoyer H, Bucsky P. Number of genomic imbalances correlates with the overall survival for adrenocortical cancer in childhood. Pediatric Blood and Cancer 2008 51 356362. (https://doi.org/10.1002/pbc.21603)

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 38

    Mayer SK, Oligny LL, Deal C, Yazbeck S, Gagné N, Blanchard H. Childhood adrenocortical tumors: case series and reevaluation of prognosis – a 24-year experience. Journal of Pediatric Surgery 1997 32 911915. (https://doi.org/10.1016/s0022-3468(9790649-7)

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 39

    Michalkiewicz EL, Sandrini R, Bugg MF, Cristofani L, Caran E, Cardoso AM, de Lacerda L, Ribeiro RC. Clinical characteristics of small functioning adrenocortical tumors in children. Medical and Pediatric Oncology 1997 28 175178. (https://doi.org/10.1002/(sici)1096-911x(199703)28:3<175::aid-mpo3>3.0.co;2-g)

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 40

    Mishra A, Agarwal G, Misra AK, Agarwal A, Mishra SK. Functioning adrenal tumours in children and adolescents: an institutional experience. ANZ Journal of Surgery 2001 71 103107. (https://doi.org/10.1046/j.1440-1622.2001.02045.x)

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 41

    Mittal R, Ramadan DG, Khalifa NM, Khalifa SO, Mazidi Z, Zaki M. Adrenocortical tumors in children: a Kuwait experience. Gulf Journal of Oncology 2012 12 3846.

  • 42

    Narasimhan KL, Samujh R, Bhansali A, Marwaha RK, Chowdhary SK, Radotra BD, Rao KL. Adrenocortical tumors in childhood. Pediatric Surgery International 2003 19 432435. (https://doi.org/10.1007/s00383-002-0727-1)

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 43

    Panamonta O, Areemit S, Srinakarin J, Siritunyaporn S, Tuksapun S. Adrenocortical tumors in children. Journal of the Medical Association of Thailand 2001 84 188194.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 44

    Parise IZS, Parise GA, Noronha L, Surakhy M, Woiski TD, Silva DB, Costa TEB, Del-Valle MHCP, Komechen H & Rosati R et al.The prognostic role of CD8(+) T lymphocytes in childhood adrenocortical carcinomas compared to Ki-67, PD-1, PD-L1, and the Weiss score. Cancers 2019 11 1730. (https://doi.org/10.3390/cancers11111730)

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 45

    Sakoda A, Mushtaq I, Levitt G, Sebire NJ. Clinical and histopathological features of adrenocortical neoplasms in children: retrospective review from a single specialist center. Journal of Pediatric Surgery 2014 49 410415. (https://doi.org/10.1016/j.jpedsurg.2013.09.008)

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 46

    Stewart JN, Flageole H, Kavan P. A surgical approach to adrenocortical tumors in children: the mainstay of treatment. Journal of Pediatric Surgery 2004 39 759763. (https://doi.org/10.1016/j.jpedsurg.2004.01.029)

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 47

    Wang J, Qi F, Zhang P, Xu Z, Zheng Y, Cai H, Yu B, Xu T, Li X, Zou Q. Clinical characteristics and genetic testing of an atypical familial von Hippel-Lindauzon renal cell carcinoma. Annals of Translational Medicine 2019 7 677. (https://doi.org/10.21037/atm.2019.10.09)

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 48

    Wu X, Xu J, Wang J, Gu W, Zou C. Childhood adrenocortical tumor: a clinical and immunohistochemical study of 13 cases. Medicine 2019 98 e17921. (https://doi.org/10.1097/MD.0000000000017921)

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 49

    Zancanella P, Pianovski MA, Oliveira BH, Ferman S, Piovezan GC, Lichtvan LL, Voss SZ, Stinghen ST, Callefe LG & Parise GA et al.Mitotane associated with cisplatin, etoposide, and doxorubicin in advanced childhood adrenocortical carcinoma: mitotane monitoring and tumor regression. Journal of Pediatric Hematology/Oncology 2006 28 513524. (https://doi.org/10.1097/01.mph.0000212965.52759.1c)

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 50

    Zerbini C, Kozakewich HPW, Weinberg DS, Mundt DJ, Edwards JA, Lack EE. Adrenocortical neoplasms in childhood and adolescence: analysis of prognostic factors including DNA content. Endocrine Pathology 1992 3 116128. (https://doi.org/10.1007/BF02921352)

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 51

    Mattone MC, Gil S, Costanzo M, Galluzzo Mutti ML, Casanovas A, Zaidman V, Lazzati JM, Ciaccio M, Belgorosky A, Guercio G. Pediatric adrenocortical tumors cohort characteristics and long-term follow-up at a single Argentinian tertiary center. Journal of Pediatric Endocrinology and Metabolism 2022 35 1927. (https://doi.org/10.1515/jpem-2021-0392)

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 52

    Cordeiro AM, Da Graca Bicalho M, Marques-Pereira R, Franca PP, Moraes MM, Rezende GYT, Nesi-Franca S, Sandrini R, De Lacerda L. Allelic frequencies of HLA-A, HLA-B and HLA-DRB1 genes in patients with adrenocortical tumor carriers of the germline mutation R337H in the TP53 gene. Endocrine Reviews 2012 33.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 53

    Rodriguez-Galindo C, Krailo MD, Pinto EM, Pashankar F, Weldon CB, Huang L, Caran EM, Hicks J, McCarville MB & Malkin D et al.Treatment of pediatric adrenocortical carcinoma with surgery, retroperitoneal lymph node dissection, and chemotherapy: the Children’s Oncology Group ARAR0332 protocol. Journal of Clinical Oncology 2021 39 24632473. (https://doi.org/10.1200/JCO.20.02871)

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 54

    Ribeiro RC, Sandrini Neto RS, Schell MJ, Lacerda L, Sambaio GA, Cat I. Adrenocortical carcinoma in children: a study of 40 cases. Journal of Clinical Oncology 1990 8 6774. (https://doi.org/10.1200/JCO.1990.8.1.67)

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 55

    Virgone C, Roganovic J, Vorwerk P, Redlich A, Schneider DT, Janic D, Bien E, Lopez-Almaraz R, Godzinski J & Osterlundh G et al.Adrenocortical tumours in children and adolescents: the EXPeRT/PARTNER diagnostic and therapeutic recommendations. Pediatric Blood and Cancer 2021 68 (Supplement 4) e29025. (https://doi.org/10.1002/pbc.29025)

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 56

    Cagle PT, Hough AJ, Pysher TJ, Page DL, Johnson EH, Kirkland RT, Holcombe JH, Hawkins EP. Comparison of adrenal cortical tumors in children and adults. Cancer 1986 57 22352237. (https://doi.org/10.1002/1097-0142(19860601)57:11<2235::aid-cncr2820571127>3.0.co;2-o)

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 57

    Picard C, Orbach D, Carton M, Brugieres L, Renaudin K, Aubert S, Berrebi D, Galmiche L, Dujardin F & Leblond P et al.Revisiting the role of the pathological grading in pediatric adrenal cortical tumors: results from a national cohort study with pathological review. Modern Pathology 2019 32 546559. (https://doi.org/10.1038/s41379-018-0174-8)

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 58

    Blavier L, Yang RM, DeClerck YA. The tumor microenvironment in neuroblastoma: new players, new mechanisms of interaction and new perspectives. Cancers 2020 12 2912. (https://doi.org/10.3390/cancers12102912)

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 59

    Lane DP Cancer. p53, guardian of the genome. Nature 1992 358 1516. (https://doi.org/10.1038/358015a0)

  • 60

    Gulack BC, Rialon KL, Englum BR, Kim J, Talbot LJ, Adibe OO, Rice HE, Tracy ET. Factors associated with survival in pediatric adrenocortical carcinoma: an analysis of the National Cancer Data Base (NCDB). Journal of Pediatric Surgery 2016 51 172177. (https://doi.org/10.1016/j.jpedsurg.2015.10.039)

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 61

    Martins-Filho SN, Almeida MQ, Soares I, Wakamatsu A, Alves VAF, Fragoso MCBV, Zerbini MCN. Clinical impact of pathological features including the Ki-67 labeling index on diagnosis and prognosis of adult and pediatric adrenocortical tumors. Endocrine Pathology 2021 32 288300. (https://doi.org/10.1007/s12022-020-09654-x)

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 62

    Pinto EM, Rodriguez-Galindo C, Pounds SB, Wang L, Clay MR, Neale G, Garfinkle EAR, Lam CG, Levy CF & Pappo AS et al.Identification of clinical and biologic correlates associated with outcome in children with adrenocortical tumors without germline TP53 mutations: ASt Jude Adrenocortical Tumor Registry and Children’s Oncology Group study. Journal of Clinical Oncology 2017 35 39563963. (https://doi.org/10.1200/JCO.2017.74.2460)

    • PubMed
    • Search Google Scholar
    • Export Citation